Li Kang Biomedical Co Ltd (6242) — Net Asset Quality Index
Li Kang Biomedical Co Ltd (6242) has a Net Asset Quality Index of 79.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$1.09 Billion minus total liabilities of NT$221.82 Million yields net assets of NT$871.24 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check 6242 financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Li Kang Biomedical Co Ltd Net Asset Quality Index Over Time (2002–2025)
This chart shows how Li Kang Biomedical Co Ltd's Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the index stands at 79.7%, representing net assets of NT$871.24 Million against total assets of NT$1.09 Billion TWD. See Li Kang Biomedical Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Li Kang Biomedical Co Ltd (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for Li Kang Biomedical Co Ltd from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Li Kang Biomedical Co Ltd market capitalisation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.7% | NT$871.24 Million | NT$1.09 Billion | NT$221.82 Million | ▼ -2.9 pp |
| 2024 | 82.6% | NT$855.68 Million | NT$1.04 Billion | NT$179.93 Million | ▲ +6.4 pp |
| 2023 | 76.2% | NT$630.03 Million | NT$827.00 Million | NT$196.97 Million | ▼ -6.6 pp |
| 2022 | 82.8% | NT$570.14 Million | NT$688.84 Million | NT$118.70 Million | ▲ +2.9 pp |
| 2021 | 79.9% | NT$492.00 Million | NT$616.07 Million | NT$124.07 Million | ▲ +1.0 pp |
| 2020 | 78.8% | NT$508.30 Million | NT$644.77 Million | NT$136.46 Million | ▲ +1.7 pp |
| 2019 | 77.2% | NT$483.44 Million | NT$626.44 Million | NT$143.00 Million | ▲ +0.6 pp |
| 2018 | 76.6% | NT$466.92 Million | NT$609.85 Million | NT$142.93 Million | ▲ +1.8 pp |
| 2017 | 74.8% | NT$445.68 Million | NT$596.06 Million | NT$150.38 Million | ▲ +13.3 pp |
| 2016 | 61.4% | NT$340.80 Million | NT$554.77 Million | NT$213.96 Million | ▲ +8.2 pp |
| 2015 | 53.2% | NT$280.29 Million | NT$526.73 Million | NT$246.44 Million | ▼ -16.9 pp |
| 2014 | 70.1% | NT$227.44 Million | NT$324.37 Million | NT$96.93 Million | ▲ +48.4 pp |
| 2013 | 21.7% | NT$24.29 Million | NT$111.79 Million | NT$87.50 Million | ▼ -36.0 pp |
| 2012 | 57.7% | NT$85.12 Million | NT$147.57 Million | NT$62.45 Million | ▼ -9.8 pp |
| 2011 | 67.5% | NT$123.43 Million | NT$182.81 Million | NT$59.37 Million | ▼ -0.2 pp |
| 2010 | 67.8% | NT$104.31 Million | NT$153.96 Million | NT$49.65 Million | ▲ +16.9 pp |
| 2009 | 50.8% | NT$128.49 Million | NT$252.83 Million | NT$124.35 Million | ▲ +7.2 pp |
| 2008 | 43.6% | NT$191.32 Million | NT$438.89 Million | NT$247.58 Million | ▼ -15.0 pp |
| 2007 | 58.6% | NT$411.54 Million | NT$701.86 Million | NT$290.32 Million | ▲ +30.1 pp |
| 2006 | 28.5% | NT$215.94 Million | NT$757.63 Million | NT$541.69 Million | ▲ +0.3 pp |
| 2005 | 28.2% | NT$223.45 Million | NT$791.11 Million | NT$567.66 Million | ▼ -14.0 pp |
| 2004 | 42.2% | NT$323.44 Million | NT$766.35 Million | NT$442.91 Million | ▼ -1.7 pp |
| 2003 | 43.9% | NT$338.06 Million | NT$770.15 Million | NT$432.09 Million | ▼ -1.5 pp |
| 2002 | 45.4% | NT$347.64 Million | NT$765.96 Million | NT$418.31 Million | — |